Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.
GSK’s ViiV Healthcare and its bimonthly pre-exposure prophylaxis (PrEP) medicine Apretude had to make room for another ...
SinoMab Bioscience Ltd. ( ($HK:3681) ) has shared an update. SinoMab BioScience Limited announced the successful dosing of the first cohort of ...
Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Panelists discuss how the IMscin001 trial findings established subcutaneous atezolizumab noninferiority with comparable efficacy and safety to intravenous (IV) formulation while highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback